Thursday May 25th 2017

‘Nonprofit’ Archives

BBC Breakfast feature on CCSVI – 11 February 2010

BBC Breakfast feature on CCSVI – 11 February 2010

BBC Breakfast feature on CCSVI announcement from 11 February 2010. Features a brief interview with Dr Doug Brown, Biomedical Research Manager from the MS Society. Please note that the interview was filmed BEFORE the announcement of the Buffalo study results on 10 February [Read More]

2nd Part CCSVI Why time is our enemy

2nd Part CCSVI Why time is our enemy

2nd part of the video. What is considered a medical break trhrough? Ideas for who you can contact to help spreak the word about CCSVI. Here is a link to a petition I started for more studies and coverage in the US Well I went ahead and made a petition for the United States [Read More]

MS Society comments on CCSVI announcement live on Sky News

MS Society comments on CCSVI announcement live on Sky News

Sky News feature on CCSVI announcement – 10 February 2010. Features an interview with Dr Doug Brown, Biomedical Research Manager from the MS Society. Footage courtesy of Sky News. Posted by Sam Daniels [Read More]

 Page 1 of 3  1  2  3 »

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]